Statements (74)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:virus
|
| gptkbp:belongs_to |
gptkb:virus
|
| gptkbp:caused_by |
respiratory infections
|
| gptkbp:communication |
respiratory droplets
|
| gptkbp:genetic_diversity |
positive-sense single-stranded RNA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Betacoronavirus
|
| gptkbp:includes |
gptkb:MERS-Co_V
gptkb:SARS-Co_V gptkb:SARS-Co_V-2 |
| gptkbp:is_aimed_at |
antiviral drugs
|
| gptkbp:is_associated_with |
gptkb:COVID-19
acute respiratory distress syndrome pandemics Middle East respiratory syndrome severe acute respiratory syndrome |
| gptkbp:is_characterized_by |
membrane protein
envelope protein enveloped structure nucleocapsid protein spike protein |
| gptkbp:is_found_in |
gptkb:civet_cats
bats camels |
| gptkbp:is_monitored_by |
gptkb:CDC
gptkb:WHO |
| gptkbp:is_part_of |
coronavirus family
viral taxonomy |
| gptkbp:is_recognized_by |
genetic sequencing
|
| gptkbp:is_related_to |
gptkb:common_cold_coronaviruses
|
| gptkbp:is_studied_in |
gptkb:quarantine_measures
community engagement clinical trials immune response public awareness campaigns risk factors economic impact epidemiological studies contact tracing mask mandates treatment protocols vaccine efficacy clinical outcomes vaccine distribution vaccine development vaccine hesitancy travel restrictions global health security social distancing measures diagnostic methods treatment options public health impact infectious disease control public health messaging viral load viral evolution pathogenesis transmission dynamics surveillance strategies host interactions vaccine rollout community transmission healthcare preparedness healthcare worker safety mental health impact zoonotic spillover |
| gptkbp:is_subject_to |
public health measures
|
| gptkbp:scientific_classification |
gptkb:Group_2_B_virus
|
| gptkbp:symptoms |
fatigue
cough fever shortness of breath loss of taste or smell |